CD274 and cancer: However, the epitope of BMS-936559 occupies a large part of the PD-1 binding site (Fig. 5b); in addition, high avidity, resulting from IgG bivalency, is expected due to the high expression level of PD-L1 in many cancer types36, leading to efficient blockade of the PD-1/PD-L1 interaction.